[HTML][HTML] Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse …
M Moustafa, KK Dähling, A Günther, L Riebandt… - Cancers, 2022 - mdpi.com
Simple Summary Cancer stem cells are a distinct tumor subpopulation associated with poor
outcome. The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen …
outcome. The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen …
[PDF][PDF] Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse …
M Moustafa, KK Dähling, A Günther, L Riebandt… - …, 2022 - mediatum.ub.tum.de
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model.
M Moustafa, KK Dähling, A Günther, L Riebandt… - Cancers, 2022 - europepmc.org
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
[HTML][HTML] Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse …
M Moustafa, KK Dähling, A Günther, L Riebandt… - Cancers, 2022 - ncbi.nlm.nih.gov
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
[PDF][PDF] Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse …
M Moustafa, KK Dähling, A Günther, L Riebandt… - …, 2016 - pdfs.semanticscholar.org
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model
M Moustafa, KK Dähling, A Günther, L Riebandt… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model
M Moustafa, KK Dähling, A Günther, L Riebandt… - …, 2022 - search.proquest.com
The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface antigen (CD90) have
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
been implicated as cancer stem cell (CSC) markers in hepatocellular carcinoma (HCC) …
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model.
M Moustafa, KK Dähling, A Günther, L Riebandt… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Cancer stem cells are a distinct tumor subpopulation associated
with poor outcome. The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface …
with poor outcome. The epithelial cell adhesion molecule (EpCAM) and Thy-1 cell surface …